Purchase one-time access:Academic and Personal
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Obstetrics and Gynaecology Canada
- Intravenous administration of splenocytes in early pregnancy changes the implantation window in mice.Hum Reprod. 1997; 12: 583-585
- Splenocytes in early pregnancy promote embryo implantation by regulating endometrial differentiation in mice.Hum Reprod. 1997; 12: 2102-2107
- Administration of thymocytes derived from nonpregnant mice induces an endometrial receptive stage and leukaemia inhibitory factor expression in the uterus.Hum Reprod. 1998; 13: 2888-2894
- Human peripheral blood mononuclear cells enhance cell-cell interaction between human endometrial epithelial cells and BeWo-cell spheroids.Hum Reprod. 2003; 18: 19-25
- Human peripheral blood mononuclear cells (PBMC) in early pregnancy promote embryo invasion in vitro: HCG enhances the effects of PBMC.Hum Reprod. 2002; 17: 207-212
- Human chorionic gonadotropin (HCG) activates monocytes to produce interleukin-8 via a different pathway from luteinizing hormone/HCG receptor system.J Clin Endocrinol Metab. 2002; 87: 5199-5208
- Immune cells contribute to systemic cross-talk between the embryo and mother during early pregnancy in cooperation with the endocrine system.Reprod Med Biol. 2006; 5: 19-29
- Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer.Hum Reprod. 2006; 21: 3290-3294
- Intrauterine administration of autologous peripheral blood mononuclear cells increases clinical pregnancy rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure.J Reprod Immunol. 2011; 92: 82-87
- Intrauterine insemination of cultured peripheral blood mononuclear cells prior to embryo transfer improves clinical outcome for patients with repeated implantation failures.Zygote. 2016; 24: 58-69
- Repeated implantation failure: a new potential treatment option.Eur J Clin Invest. 2015; 45: 380-384
- Intrauterine administration of autologous peripheral blood mononuclear cells (PBMCs) activated by HCG improves the implantation and pregnancy rates in patients with repeated implantation failure: a prospective randomized study.Am J Reprod Immunol. 2016; 76: 212-216
- Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure.J Reprod Immunol. 2017; 119: 15-22
- Endometrium immunomodulation by intrauterine insemination administration of treated peripheral blood mononuclear cell prior frozen/thawed embryos in patients with repeated implantation failure.Zygote. 2019; 27: 214-218
- Intrauterine insemination.(Available at:)Accessed on February 23, 2021)
- Predictive factors for intrauterine insemination outcomes: a review.Fertil Res Pract. 2020; 6: 23
- Role of T cells in intrauterine administration of activated peripheral blood mononuclear cells in recurrent implantation failure.bioRxiv. 2021; (2021.01.06.425452)
- Sample size estimation in clinical trial.Perspect Clin Res. 2010; 1: 67-69
- Recurrent implantation failure-update overview on etiology, diagnosis, treatment and future directions.Reprod Biol Endocrinol. 2018; 16: 121
- Does intra-uterine insemination have a place in modern ART practice?.Best Pract Res Clin Obstet Gynaecol. 2018; 53: 3-10
- Repeated implantation failure: clinical approach.Fertil Steril. 2012; 97: 1039-1043
- Th1/Th2 balance of the implantation site in humans.Immunol Pregnancy. 2007; : 37-58
- Contribution of immunology to implantation failure of euploid embryos.Fertil Steril. 2017; 107: 1279-1283
- Regulatory T cells in embryo implantation and the immune response to pregnancy.J Clin Invest. 2018; 128: 4224-4235
- Th22 cells form a distinct Th lineage from Th17 cells in vitro with unique transcriptional properties and Tbet-dependent Th1 plasticity.J Immunol. 2017; 198: 2182-2190
Publication stageIn Press Journal Pre-Proof
Disclosures: This research was supported by Mitacs Accelerate (Grant IT-11313 ). Pierre Miron is the owner, CEO, and president of Fertilys, Inc. All other authors have no conflict of interest to declare.
All authors have indicated they meet the journal’s requirements for authorship.